Journal Article

Final overall survival analysis of patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) treated with sorafenib in the phase 3 DECISION trial: An exploratory crossover adjustment analyses

M. Brose, B. Jarzab, R. Elisei, L. Giannetta, L. Bastholt, C. de la Fouchardiere, F. Pacini, R. Paschke, C. Nutting, Y.K. Shong, S. Sherman, J. Smit, J. Chung, G. Meinhardt, M. Schlumberger and C. Kappeler

in Annals of Oncology

Published on behalf of European Society for Medical Oncology

Volume 27, issue suppl_6 Published in print October 2016 | ISSN: 0923-7534
Published online October 2016 | e-ISSN: 1569-8041 | DOI: http://dx.doi.org/10.1093/annonc/mdw376.06
Final overall survival analysis of patients with locally advanced or metastatic radioactive iodine-refractory differentiated thyroid cancer (RAI-rDTC) treated with sorafenib in the phase 3 DECISION trial: An exploratory crossover adjustment analyses

Show Summary Details

Journal Article.  601 words. 

Subjects: Medical Oncology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.